Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco Products | 34 | 2024 | 190 | 10.510 |
Why?
|
| Alcohol Drinking | 18 | 2023 | 162 | 7.280 |
Why?
|
| Cannabis | 10 | 2024 | 41 | 5.330 |
Why?
|
| Tobacco Use Disorder | 12 | 2022 | 115 | 4.750 |
Why?
|
| Substance-Related Disorders | 17 | 2023 | 166 | 4.600 |
Why?
|
| Marijuana Smoking | 9 | 2023 | 31 | 4.520 |
Why?
|
| Smoking Cessation | 22 | 2025 | 398 | 4.510 |
Why?
|
| Cigarette Smoking | 13 | 2023 | 77 | 4.400 |
Why?
|
| Smoking | 21 | 2023 | 466 | 4.010 |
Why?
|
| Tobacco Use | 14 | 2022 | 83 | 3.980 |
Why?
|
| Menthol | 8 | 2022 | 18 | 3.480 |
Why?
|
| Electronic Nicotine Delivery Systems | 16 | 2023 | 194 | 3.390 |
Why?
|
| Marijuana Use | 10 | 2024 | 32 | 2.870 |
Why?
|
| Adolescent | 45 | 2024 | 2955 | 2.810 |
Why?
|
| Sexual and Gender Minorities | 5 | 2024 | 36 | 2.710 |
Why?
|
| Young Adult | 46 | 2024 | 2580 | 2.670 |
Why?
|
| Adult | 54 | 2025 | 7381 | 2.090 |
Why?
|
| Humans | 82 | 2025 | 26828 | 1.890 |
Why?
|
| Tobacco Smoking | 4 | 2023 | 38 | 1.760 |
Why?
|
| Female | 58 | 2025 | 14456 | 1.760 |
Why?
|
| Male | 54 | 2025 | 12868 | 1.670 |
Why?
|
| United States | 27 | 2023 | 2031 | 1.580 |
Why?
|
| Prevalence | 15 | 2023 | 472 | 1.580 |
Why?
|
| Alcoholism | 5 | 2018 | 116 | 1.570 |
Why?
|
| Smokers | 9 | 2022 | 124 | 1.480 |
Why?
|
| Motivation | 7 | 2025 | 207 | 1.430 |
Why?
|
| Smoking Prevention | 5 | 2019 | 87 | 1.330 |
Why?
|
| Marketing | 7 | 2024 | 34 | 1.330 |
Why?
|
| Nicotine | 5 | 2022 | 82 | 1.180 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2017 | 4 | 1.110 |
Why?
|
| Depressive Disorder, Major | 4 | 2018 | 125 | 1.060 |
Why?
|
| Alcohol-Related Disorders | 3 | 2016 | 12 | 1.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2017 | 27 | 1.040 |
Why?
|
| Internet | 8 | 2019 | 121 | 0.990 |
Why?
|
| Cognition | 4 | 2021 | 294 | 0.940 |
Why?
|
| African Americans | 3 | 2022 | 350 | 0.920 |
Why?
|
| Hallucinogens | 1 | 2024 | 12 | 0.900 |
Why?
|
| Students | 4 | 2018 | 188 | 0.900 |
Why?
|
| Rape | 2 | 2014 | 3 | 0.880 |
Why?
|
| Medical Marijuana | 1 | 2023 | 4 | 0.880 |
Why?
|
| Crime Victims | 2 | 2014 | 18 | 0.870 |
Why?
|
| Risk Factors | 12 | 2021 | 2006 | 0.860 |
Why?
|
| Marijuana Abuse | 3 | 2019 | 14 | 0.850 |
Why?
|
| Ecological Momentary Assessment | 2 | 2022 | 47 | 0.850 |
Why?
|
| Telemedicine | 3 | 2025 | 135 | 0.840 |
Why?
|
| Affect | 2 | 2014 | 82 | 0.820 |
Why?
|
| Social Networking | 3 | 2018 | 5 | 0.820 |
Why?
|
| Middle Aged | 21 | 2025 | 6813 | 0.810 |
Why?
|
| Comorbidity | 9 | 2023 | 252 | 0.810 |
Why?
|
| Social Support | 3 | 2017 | 122 | 0.810 |
Why?
|
| Risk-Taking | 3 | 2017 | 57 | 0.800 |
Why?
|
| Surveys and Questionnaires | 9 | 2024 | 917 | 0.790 |
Why?
|
| Vaping | 5 | 2023 | 123 | 0.760 |
Why?
|
| Adolescent Behavior | 2 | 2019 | 67 | 0.760 |
Why?
|
| Harm Reduction | 3 | 2019 | 7 | 0.720 |
Why?
|
| Legislation, Drug | 2 | 2018 | 4 | 0.710 |
Why?
|
| Intention | 3 | 2021 | 75 | 0.680 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 27 | 0.660 |
Why?
|
| Reward | 1 | 2019 | 45 | 0.650 |
Why?
|
| HIV Infections | 2 | 2023 | 146 | 0.650 |
Why?
|
| Heterosexuality | 3 | 2024 | 17 | 0.640 |
Why?
|
| Depression | 2 | 2018 | 210 | 0.630 |
Why?
|
| Tobacco | 4 | 2022 | 86 | 0.630 |
Why?
|
| Mental Disorders | 2 | 2018 | 103 | 0.630 |
Why?
|
| Smoking Water Pipes | 2 | 2019 | 3 | 0.610 |
Why?
|
| Racism | 1 | 2018 | 11 | 0.600 |
Why?
|
| Child | 8 | 2023 | 2146 | 0.590 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 85 | 0.590 |
Why?
|
| Social Media | 1 | 2018 | 50 | 0.580 |
Why?
|
| Universities | 3 | 2014 | 115 | 0.580 |
Why?
|
| Anxiety | 1 | 2018 | 139 | 0.580 |
Why?
|
| Ethanol | 3 | 2018 | 118 | 0.580 |
Why?
|
| Neoplasms | 2 | 2024 | 750 | 0.560 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 400 | 0.550 |
Why?
|
| Urban Population | 1 | 2016 | 70 | 0.540 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 68 | 0.520 |
Why?
|
| Text Messaging | 3 | 2021 | 21 | 0.510 |
Why?
|
| Health Surveys | 4 | 2018 | 77 | 0.510 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2019 | 279 | 0.500 |
Why?
|
| Cohort Studies | 7 | 2019 | 859 | 0.500 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 90 | 0.490 |
Why?
|
| Logistic Models | 4 | 2018 | 397 | 0.490 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 111 | 0.490 |
Why?
|
| Aged | 11 | 2024 | 5159 | 0.480 |
Why?
|
| Self Efficacy | 1 | 2015 | 72 | 0.460 |
Why?
|
| Mental Health | 4 | 2024 | 96 | 0.460 |
Why?
|
| New England | 3 | 2019 | 8 | 0.450 |
Why?
|
| Battered Women | 1 | 2012 | 2 | 0.420 |
Why?
|
| Residence Characteristics | 2 | 2024 | 100 | 0.410 |
Why?
|
| Truth Disclosure | 1 | 2012 | 24 | 0.410 |
Why?
|
| Association Learning | 1 | 2012 | 9 | 0.400 |
Why?
|
| Women's Health | 1 | 2012 | 57 | 0.400 |
Why?
|
| Flavoring Agents | 3 | 2021 | 15 | 0.380 |
Why?
|
| Oklahoma | 2 | 2024 | 973 | 0.350 |
Why?
|
| Homeless Persons | 2 | 2022 | 113 | 0.340 |
Why?
|
| Tobacco, Smokeless | 3 | 2021 | 43 | 0.340 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 298 | 0.330 |
Why?
|
| Sexual Behavior | 4 | 2023 | 87 | 0.330 |
Why?
|
| Age Factors | 4 | 2019 | 716 | 0.310 |
Why?
|
| Drug Users | 2 | 2019 | 11 | 0.310 |
Why?
|
| Minority Groups | 3 | 2023 | 61 | 0.300 |
Why?
|
| Craving | 2 | 2017 | 15 | 0.280 |
Why?
|
| Health Behavior | 3 | 2019 | 153 | 0.270 |
Why?
|
| Feasibility Studies | 2 | 2025 | 187 | 0.260 |
Why?
|
| Pilot Projects | 2 | 2018 | 390 | 0.260 |
Why?
|
| Sex Factors | 2 | 2019 | 444 | 0.260 |
Why?
|
| Commerce | 2 | 2024 | 47 | 0.250 |
Why?
|
| Models, Psychological | 2 | 2018 | 80 | 0.240 |
Why?
|
| Time Factors | 2 | 2023 | 1563 | 0.240 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2016 | 40 | 0.240 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2024 | 6 | 0.230 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 237 | 0.220 |
Why?
|
| Health Promotion | 3 | 2025 | 169 | 0.210 |
Why?
|
| Tobacco Industry | 2 | 2024 | 31 | 0.210 |
Why?
|
| Smoke | 1 | 2021 | 36 | 0.190 |
Why?
|
| Underage Drinking | 2 | 2018 | 5 | 0.180 |
Why?
|
| Quality of Life | 1 | 2024 | 462 | 0.180 |
Why?
|
| Exercise | 1 | 2025 | 451 | 0.180 |
Why?
|
| Probability | 1 | 2019 | 75 | 0.170 |
Why?
|
| Economics, Behavioral | 1 | 2019 | 2 | 0.170 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 910 | 0.170 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 12 | 0.170 |
Why?
|
| Automobile Driving | 1 | 2019 | 9 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 340 | 0.170 |
Why?
|
| Odds Ratio | 1 | 2019 | 231 | 0.160 |
Why?
|
| Taste | 1 | 2019 | 26 | 0.160 |
Why?
|
| Patient Preference | 1 | 2019 | 28 | 0.160 |
Why?
|
| Nicotinic Agonists | 1 | 2018 | 3 | 0.160 |
Why?
|
| Virginia | 1 | 2018 | 3 | 0.160 |
Why?
|
| Alcoholic Beverages | 1 | 2018 | 4 | 0.160 |
Why?
|
| Peer Group | 1 | 2018 | 36 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2018 | 85 | 0.150 |
Why?
|
| Water Pipe Smoking | 1 | 2017 | 8 | 0.150 |
Why?
|
| Research | 1 | 2018 | 88 | 0.150 |
Why?
|
| Machine Learning | 1 | 2018 | 79 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2018 | 86 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 46 | 0.150 |
Why?
|
| Public Health | 1 | 2018 | 84 | 0.140 |
Why?
|
| Criminals | 1 | 2017 | 2 | 0.140 |
Why?
|
| Taxes | 1 | 2017 | 12 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2018 | 93 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2017 | 67 | 0.140 |
Why?
|
| Smoke-Free Policy | 1 | 2017 | 15 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 102 | 0.140 |
Why?
|
| Central Nervous System Depressants | 2 | 2018 | 13 | 0.140 |
Why?
|
| Interviews as Topic | 1 | 2017 | 150 | 0.140 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 5 | 0.140 |
Why?
|
| Public Opinion | 1 | 2016 | 8 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 472 | 0.140 |
Why?
|
| Product Labeling | 1 | 2016 | 10 | 0.130 |
Why?
|
| Consumer Behavior | 1 | 2016 | 14 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 117 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2016 | 45 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2017 | 172 | 0.130 |
Why?
|
| Methadone | 1 | 2016 | 17 | 0.130 |
Why?
|
| Income | 1 | 2015 | 38 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2016 | 75 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2017 | 209 | 0.120 |
Why?
|
| Data Collection | 1 | 2015 | 101 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 93 | 0.120 |
Why?
|
| Association | 1 | 2013 | 4 | 0.110 |
Why?
|
| Research Design | 1 | 2015 | 174 | 0.110 |
Why?
|
| Linear Models | 1 | 2013 | 201 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2013 | 388 | 0.110 |
Why?
|
| Police | 1 | 2012 | 5 | 0.110 |
Why?
|
| Sampling Studies | 1 | 2012 | 23 | 0.100 |
Why?
|
| Alcoholic Intoxication | 1 | 2012 | 4 | 0.100 |
Why?
|
| Shame | 1 | 2012 | 6 | 0.100 |
Why?
|
| Social Perception | 1 | 2012 | 23 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 46 | 0.100 |
Why?
|
| Psychological Tests | 1 | 2012 | 21 | 0.100 |
Why?
|
| Avoidance Learning | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cues | 1 | 2012 | 38 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2012 | 209 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2010 | 53 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2018 | 1216 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 747 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 241 | 0.070 |
Why?
|
| District of Columbia | 1 | 2024 | 8 | 0.060 |
Why?
|
| Recurrence | 2 | 2017 | 315 | 0.050 |
Why?
|
| Gender Identity | 1 | 2022 | 20 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 115 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 43 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 145 | 0.040 |
Why?
|
| Social Identification | 1 | 2017 | 4 | 0.040 |
Why?
|
| Self Report | 1 | 2018 | 116 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 1130 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 39 | 0.040 |
Why?
|
| Cotinine | 1 | 2017 | 45 | 0.040 |
Why?
|
| Saliva | 1 | 2017 | 94 | 0.030 |
Why?
|
| Crowdsourcing | 1 | 2016 | 3 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 82 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2016 | 53 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 702 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 356 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 733 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 1924 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2262 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 56 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 9957 | 0.010 |
Why?
|